Advanced company searchLink opens in new window

INAPHAEA BIOLABS LIMITED

Company number 14589984

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Jan 2025 CS01 Confirmation statement made on 12 January 2025 with no updates
16 Aug 2024 AP01 Appointment of Dr Mark Edward Eccleston as a director on 15 August 2024
16 Aug 2024 TM01 Termination of appointment of Suzanne Jane Dilly as a director on 15 August 2024
14 Jun 2024 AA Audit exemption subsidiary accounts made up to 31 December 2023
14 Jun 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/23
14 Jun 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/23
14 Jun 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/23
02 Mar 2024 CH01 Director's details changed for Dr Suzanne Dilly on 29 February 2024
12 Jan 2024 CS01 Confirmation statement made on 12 January 2024 with updates
28 Feb 2023 SH01 Statement of capital following an allotment of shares on 28 February 2023
  • GBP 100
28 Feb 2023 AP01 Appointment of Dr Suzanne Dilly as a director on 28 February 2023
28 Feb 2023 PSC02 Notification of Valirx Plc as a person with significant control on 28 February 2023
28 Feb 2023 PSC07 Cessation of Gerry Desler as a person with significant control on 28 February 2023
20 Jan 2023 CH01 Director's details changed for Mr Gerry Desler on 20 January 2023
20 Jan 2023 CH03 Secretary's details changed for Mr Gerry Desler on 20 January 2023
13 Jan 2023 AA01 Current accounting period shortened from 31 January 2024 to 31 December 2023
13 Jan 2023 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2023-01-13
  • GBP 1